YorkBridge Wealth Partners’s Anika Therapeutics ANIK Stock Holding History

YorkBridge Wealth Partners’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-20	Closed	-$1K	–	752
2018 Q2	$1K	Sell	20 -21	-51%	-$865	﹤0.01%	819
2018 Q1	$2K	Buy	41 +12	+41%	+$678	﹤0.01%	759
2017 Q4	$2K	Buy	29 +7	+32%	+$387	﹤0.01%	784
2017 Q3	$1K	Hold	22	–	–	﹤0.01%	831
2017 Q2	$1K	Hold	22	–	–	﹤0.01%	823
2017 Q1	$1K	Buy	+22	New	+$1.05K	﹤0.01%	813

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

YorkBridge Wealth Partners's ANIK Position: Q3 2018 in Review

YorkBridge Wealth Partners sold out of Anika Therapeutics (ANIK) in Q3 2018, closing a stake of 20 shares — an estimated $1K sold.

YorkBridge Wealth Partners first reported a position in ANIK in Q1 2017 and held it in 6 quarters. The position peaked at $2K in Q1 2018. 161 funds tracked by Wall St. Rank hold ANIK as of Q3 2018.

YorkBridge Wealth Partners reported no remaining Anika Therapeutics position as of Q3 2018 after selling out during the quarter.
YorkBridge Wealth Partners sold 20 Anika Therapeutics shares in Q3 2018, an estimated $1K.
YorkBridge Wealth Partners first reported a position in Anika Therapeutics in Q1 2017 and held it in 6 quarters.
YorkBridge Wealth Partners's Anika Therapeutics position peaked at $2K in Q1 2018.
161 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2018.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2018, filed 14 Nov 2018.